All companies
Visit website
NeuraMetrix
OperatingNeuraMetrix, Inc.
Healthcare · Technology · Founded 2022
Monitor brain health by enabling measurement of disease, diagnosis, treatment for neurological diseases and phychiatric disorders
Latest valuation ⓘ
$9.4M
Total raised
$11,538
Across 1 round since 2023
Latest share price
$9.00
Reg CF Offering (2023) offering price
Financials
FY2021–FY2025 · from SEC filings · hover any figure for its source$0
2021
$15K
−$55K
2022
$23K
−$58K
2023
$0
−$48K
2024
$0
−$64K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$15,300
$22,885
$0
$0
Cost of goods sold
$0
$17,927
$17,936
$22,265
$0
Gross margin
—
-17%
22%
—
—
Net income
$0
-$54,784
-$58,223
-$48,478
-$64,039
Taxes paid
$0
$0
$200
$200
$200
Balance sheet
Cash
$0
$64
$529
$457
$562
Accounts receivable
$0
$1,040
$1,044
$1,044
$1,040
Total assets
$0
$1,103
$1,973
$1,902
$2,002
Short-term debt
$0
$17,843
$89,236
$113,866
$157,945
Long-term debt
$0
$0
$0
$0
$0
Total liabilities
$0
$17,843
$89,236
$113,866
$157,945
Other
Headcount
—
4
—
4
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Fundraising history
Raised $11.5K / $1.2M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 3 annual reports (FY2023–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001990079Share price $9.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.